Print

PPD, Inc. (PPDI) and Global Allergy and Asthma European Network (GA2LEN) Announce Strategic Alliance in Allergic Diseases  
9/13/2012 9:53:56 AM

WILMINGTON, N.C., & BERLIN, Germany--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) and the Global Allergy and Asthma European Network e.V. (GA2LEN) today announced a strategic alliance in which GA2LEN will provide PPD access to the network’s allergy and asthma experts and to more than 100 allergy and asthma sites in Europe.